3,4-Methylenedioxy-N-isopropylamphetamine
(Redirected from Methylenedioxyisopropylamphetamine)
This article relies largely or entirely on a single source. (August 2016) |
3,4-Methylenedioxy-N-isopropylamphetamine (MDIP, MDIPA) is a psychoactive drug of the phenethylamine and amphetamine chemical classes which acts as an entactogen, psychedelic, and stimulant. It is the N-isopropyl analogue of 3,4-methylenedioxyamphetamine (MDA). MDIP was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 250 mg.[1] MDIP produces a mild threshold. Very little is known about the pharmacology, pharmacokinetics, effects, and toxicity of MDIP.
Names | |
---|---|
Preferred IUPAC name
1-(2H-1,3-Benzodioxol-5-yl)-N-(propan-2-yl)propan-2-amine | |
Other names
3,4-Methylenedioxy-N-isopropylamphetamineamine
3,4-Methylenedioxy-1-(alpha-methyl-amino-isopropyl)-ethane | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C13H19NO2 | |
Molar mass | 221.300 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
References
edit